RXi Pharmaceuticals 2017 Biotech Showcase Presentation

RXi Pharmaceuticals presented its RNAi therapeutic platform at the 2017 Biotech Showcase. The company leverages proprietary self-delivering RNA (sd-rxRNA) technology to silence overexpressed disease genes across multiple therapeutic areas. With extensive patent protection and broad applicability, RXi is developing innovative gene-silencing therapeutics.